Code | 8007D | ||||||||||
MA number | EU/1/20/1430/013 | ||||||||||
Product Form: | tbl 100x14 mg (blis.Al/Al) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Novo Nordisk A/S, Denmark | ||||||||||
Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 30 | ||||||||||
Container: | blister Al/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10b fixed combination application |
MA issued: | 03.04.2020 |
Validity: | 03.04.2025 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 28.06.2021 |